Recurrent Head and Neck Squamous Cell Carcinoma
Also known as: Recurrent Head and Neck Squamous Cell Cancer / Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN) / Recurrent Squamous Cell Carcinoma of the Head and Neck / Recurrent Squamous Cell Carcinoma of the Head or Neck
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00002 | Cetuximab | An endothelial growth factor receptor binding fragment used to treat colorectal cancer as well as squamous cell carcinoma of the head and neck. |
| DB09035 | Nivolumab | A PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma. |
| DB09037 | Pembrolizumab | A PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma. |